TORONTO, Aug. 29 /CNW/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), a leader in the research and commercial development of technologies targeting chronic inflammation underlying cardiovascular and neurological disease, today announced that it will host a conference call and a web cast slide presentation on Tuesday, September 5th, at 8:30 a.m. Eastern Time, to discuss new data from the ACCLAIM trial of its Celacade(TM) technology in patients with advanced heart failure.
